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Consortium
- REACH
- Shifts burden
of proof to business
- Science based, but
precautionary principle
- Cal. data call-in
- New York
- Mass.
- Berkeley
- Cambridge
- Decade long plan 
based on science
- Just getting started, but 
renewed push
- TSCA consent 
orders data call ins
testing rules NMSP
- Calls for TSCA  reform 
and nanospecific regulation
- Clarity
- Certainty
- CBI protection
- CBI 
- IP
- Regulation
- Insurance
- Liability
- Antitrust 
- Regulatory reform
- Good science
- Transparency
- Transparency
- Ethics
- Unbiased science
- Public input 
- Safety
Regulatory Environment
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Angstron Materials
Applied Sciences 
Continental Carbon Nanotechnologies                            
Cheap Tubes
Eikos
Nano-C
NanoLab
Nanoshel
Pyrograf Products
SouthWest NanoTechnologies
Unidym
XG Sciences
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Vince Castranova -- National Institute for Occupational 
Safety and Health
Steffi Friedrichs -- Nanotechnology Industries Association
Chuck Geraci --National Institute for Occupational Safety 
and Health
Bettye Maddux, Ph.D. -- University of Oregon
Jeffrey Morse -- University of Massachusetts, Amherst
Günter Oberdörster -- University of Rochester
Mark Tuominen --University of Massachusetts, Amherst
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Commercialization Bottleneck 
(Customers and public)
Regulatory Bottleneck
(EPA)
Contention: Given their small size and unique properties, carbon 
nanomaterials may pose unacceptable environmental, health, and safety 
risks because they can theoretically enter the environment and biological 
matricies in novel ways and cause extensive damage once there.
Less artfully . . .  carbon nanomaterials may be the next “asbestos.”
Persistent drip of studies lacking a common reference point or 
consistency of approach.
Developing Bottlenecks
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Typical TSCA CNT Consent Order
II.SUMMARY OF TERMS OF THE ORDER 
The Consent Order for this PMN substance requires the Company to: 
(1) Deliver to EPA a 1 gram sample of the PMN substance along with a copy of MSDS;
(2) Submit to EPA the results of a 90-day inhalation toxicity study in rats with a post exposure observation period of 
up to 3 months, including bronchoalveolar lavage fluid (“BALF”) analysis (OPPTS 870.3465 or OECD 413) at least 
14 weeks before either (a) manufacturing or importing a total of [  ] kg of the PMN substance, or (b) [ ] years [ ] 
months after commencing non-exempt commercial manufacture of the PMN substance, whichever comes first. The 
production/time limit shall be calculated from a date 2 years after signing this Consent Order by the Company, 
(3) Within 6 months of commencing non-exempt commercial manufacture of the PMN substance, submit certain 
material characterization data; 
(4) Use gloves impervious to nanoscale particles and chemical protective clothing; 
(5) Use a NIOSH–approved full-face respirator with an N -100 cartridge while exposed by inhalation in the work 
area; 
(6) Use the PMN substance only as a [          ]; 
(7) distribute the PMN substance only to a person who agrees to follow the same restrictions (except the testing 
requirements); and 
(8) maintain certain records. 
Typical TSC  T Consent Order
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Be proactive and address the issue 
head-on while there is still time.
Basic Concept
Create a consortium of companies to conduct joint in vivo toxicity testing of a 
representative set of carbon nanomaterials in order to satisfy EPA regulatory 
requirements and also to alleviate developing commercialization bottlenecks.  
Testing will also be coordinated with interested foreign regulatory bodies as 
appropriate.
The consortium will consist of manufacturers, suppliers, distributors, and industrial 
users of carbon nanomaterials.  The consortium shall be open to all businesses for 
which carbon nanomaterials constitute a material part of the business plans.
The consortium will be assisted by NIST, NIOSH, select universities, pertinent 
chemical and nanotechnology associations, and interested non-governmental 
organizations.
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Why Consortium?
Control own fate. Potential government/public funding got 
testing and publication.
Enhanced credibility and transparency. Shared administrative costs, expertise, 
and experiences.
Being part of a group of leaders in the 
field.
Minimize potential of rogue test findings.
Comprehensive approach to global 
regulatory needs.
NIST – Best and most credible material 
characterization experts.
Enhanced dialogue with EPA and other 
regulatory bodies.
NIOSH – Best and most credible inhalation 
experts.
Public dissemination of project and 
results.
Ability to conduct testing on a 
representative suite of materials.
Antitrust and other legal protections. Support of universities, associations, and 
NGOs.Copyright 2010
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Ensuring compliance with all pertinent 
federal and state laws.
Benefits
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Ensuring that research will satisfy Toxic 
Substances Control Act regulatory and legal 
requirements.
Benefits
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Consortium can be used for additional 
testing if regulatory and commercialization 
needs change.
Consortium can be used to address
TSCA Section 4 Testing Rules
TSCA Section 8 Data Collection Rules
Benefits
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www.nanosafetyconsortium.com
Questions?
